期刊文献+

螺内酯对2型糖尿病大鼠胰岛素抵抗的影响

Effect of Spironolactone on Insulin Resistance in Type 2 Diabetic Rats
下载PDF
导出
摘要 [目的]探讨非选择性的醛固酮受体拮抗剂——螺内酯对2型糖尿病大鼠胰岛素抵抗的影响.[方法]高糖高脂喂养加小剂量链脲佐菌素(streptozotocin,STZ)注射的方法建立2型糖尿病大鼠模型,将成模的T2DM大鼠随机分为糖尿病对照组(DM-C组)和螺内酯(SPI)干预组(DM-S组),继续予以高糖高脂饲料喂养,正常对照(NC)组大鼠继续予以普通饲料喂养,其中DM-S组予以SPI 140 mg/(kg·d)灌胃,NC组和DM-C组灌以等量蒸馏水.每两周检测大鼠的体重、血糖水平,第16周末处死大鼠,收集血液标本,检测空腹血糖(FBG)、空腹胰岛素(FINS)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、胆固醇(TC)、血钾及醛固酮(ALD)水平,计算稳态模型评估的胰岛素抵抗指数(HOMA-IR).[结果]DM-C组和DM-S组大鼠的HOMA-IR、FBG、TC、TG均明显高于NC组(均P<0.01),DM-S组TG水平低于DM-C组(P<0.05).DM-C组和DM-S组大鼠的血ALD水平高于NC组(P<0.05),但DM-C组和DM-S组之间无显著性差异(P>0.05).其余指标两组比较差异无统计学意义.三组之间血钾水平无统计学差异(P>0.05).[结论]SPI对2型糖尿病大鼠稳态模型评估的HOMA-IR没有影响,但可以降低TG水平. [Objective] To investigate the effect of nonselective aldosterone(ALD) antagonists spironolactone on insulin resistance in type 2 diabetic(T2DM) rats. [Methods]The model of T2DM rat was established by feeding with high-sucrose high-fat diet and injecting with low-dose streptozotocin(STZ). T2DM rats were randomly divided into diabetes mellitus control group(group DM-C) and spironolactone group(group DM S), and fed with high-sucrose-high fat diet continuously. The rats in normal control group(group NC) were fed with normal diet. Group DM-S was given 40 mg/(kg · day) spironolactone by lavage. Group NC and group DM-C were lavaged with isovolumic distilled water. Body weight and blood glucose of rats were determined once two weeks. The rats were killed at the end of 16 weeks. Blood samples were collected. Fasting blood glu cose(FBG), fasting insulin(FINS), HbAlc, triglyceride(TG), total cholesterol(TC), blood potassium and ALD were measured. Homeostatic model assessment(HOMA) insulin resistance index(HOMA-IR) was calculated. [Results] HOMA-IR, FBG, TC and TG in group DM-C and group DM-S were significantly higher than those in group NC(all P 〈0.01). TG level in group DM-S was lower than that in group DM-C( P 〈 0.05). There was no statistical significance in other indexes between group DM-C and group DM-S. Blood ALD in group DM-C and group DM S was higher than that in group NC( P 〈0.05), but there was no significant difference between group DM-S and group DM C( P 〉0.05). There was also no statistical significance in blood potassium among three groups( P 〉0.05). [Conclusion] Spironolactone has no influence on HOMA-IR in T2DM rats, but can reduce the TG level.
出处 《医学临床研究》 CAS 2011年第3期407-409,共3页 Journal of Clinical Research
关键词 糖尿病 非胰岛素依赖型 螺内酯/药理学 胰岛素抗药性 大鼠 diabetes mellitus,non insulin-dependent spironolactone/PD insulin resistance rats
  • 相关文献

参考文献13

  • 1Abuissa H,Jones PG,Marso SP,O'Keefe JH Jr.Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes:a meta-analysis of randomized clinical trials[J].J Am Coll Cardiol,2005,46(5):821-826.
  • 2Jandeleit-Dahm KA,Tikellis C,Reid CM,et al.Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes[J].J Hypertens,2005,23(3):463-473.
  • 3Nishimura H,Sanaka T,Tanihata Y,et al.Losartan elevates the serum high-molecular weight-adiponectin isoform and concurrently improves insulin sensitivity in patients with impaired glucose metabolism[J].Hypertens Res,2008,31(8):1611-1618.
  • 4Guo LL,Pan Y,Jin HM.Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin Ⅱ type 1 receptor blocker losartan[J].Nephrol Dial Transplant,2009,24(6):1876-1883.
  • 5Sato A,Hayashi K,Naruse M,et al.Effectiveness of aldosterone blockade in patients with diabetic nephropathy[J].Hypertension,2003,41(1):64-68.
  • 6Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.
  • 7Bermudez V,Cano R,Cano C,et al.Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes[J].Am J Ther,2008,15(4):409-416.
  • 8Struthers AD,MacDonald TM.Review of aldosterone-and angiotensin II-induced target organ damage and prevention[J].Cardiovasc Res,2004,61(4):663-670.
  • 9Bentley-Lewis R,Adler GK,Perlstein T,et al.Body mass index predicts aldosterone production in normotensive adults on a high-salt diet[J].J Clin Endocrinol Metab,2007,92(11):4472-4475.
  • 10Goodfriend TL,Egan BM,Kelley DE.Aldosterone in obesity[J].Endocr Res,1998,24(3-4):789-796.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部